|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| License and royalty | |||||
| Service | |||||
| Total revenues | |||||
| Operating Expenses | |||||
| Cost of revenues | |||||
| Cost of license and royalty revenues | |||||
| Research and development | |||||
| General and administrative | |||||
| Credit losses (recoveries) | |||||
| Impairment of long-lived assets | |||||
| Other operating expenses | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income from licensing | |||||
| Investment income | |||||
| Interest expense | |||||
| Total other income (expense) | |||||
| Loss before income taxes | |||||
| Income Tax Benefit | |||||
| Net loss | |||||
| Other Comprehensive Income (Loss) | |||||
| Unrealized gain on available-for-sale securities, net | |||||
| Total other comprehensive income | |||||
| Comprehensive loss | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted-average common shares outstanding, basic | |||||
| Weighted-average common shares outstanding, diluted | |||||
Loading...